HNRNPA2B1 and hepatocellular carcinoma: Studies have reported that miR503HG interacts with HNRNPA2B1, effectively curbing NF-κB signaling by modulating the ubiquitination status of HNRNPA2B1, consequently restraining HCC metastasis [124].